Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-25 of 41 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2

Antibody-Drug Conjugate Made of Zoledronic Acid and the Anti-CD30 Brentuximab-Vedotin Exert Anti-Lymphoma and Immunostimulating Effects.
Morelli F, Matis S, Benelli R, Salvini L, Zocchi MR, Poggi A
Cells, 13(10):862, 17 May 2024
Cited by: 0 articles | PMID: 38786084 | PMCID: PMC11119185
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Synthesis and evaluation of (E)-4-hydroxy-3-methyl-but-2-enyl diphosphate analogs as competitive partial agonists of butyrophilin 3A1.
Singh R, Rani S, Jin Y, Hsiao CC, Wiemer AJ
Eur J Med Chem, 276:116673, 14 Jul 2024
Cited by: 0 articles | PMID: 39029338
Add to export list
Priming of Colorectal Tumor-Associated Fibroblasts with Zoledronic Acid Conjugated to the Anti-Epidermal Growth Factor Receptor Antibody Cetuximab Elicits Anti-Tumor Vδ2 T Lymphocytes.
Fernandez JLC, Benelli R, Costa D, Campioli A, Tavella S, Zocchi MR, Poggi A
Cancers (Basel), 15(3):610, 18 Jan 2023
Cited by: 2 articles | PMID: 36765569 | PMCID: PMC9913507
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Targeting of colorectal cancer organoids with zoledronic acid conjugated to the anti-EGFR antibody cetuximab.
Benelli R, Costa D, Salvini L, Tardito S, Tosetti F, Villa F, Zocchi MR, Poggi A
J Immunother Cancer, 10(12):e005660, 01 Dec 2022
Cited by: 10 articles | PMID: 36543375 | PMCID: PMC9772689
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Reducing farnesyl diphosphate synthase levels activates Vγ9Vδ2 T cells and improves tumor suppression in murine xenograft cancer models.
Liou ML, Lahusen T, Li H, Xiao L, Pauza CD
Front Immunol, 13:1012051, 05 Oct 2022
Cited by: 1 article | PMID: 36275712 | PMCID: PMC9581136
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
PD-1 checkpoint blockade enhances adoptive immunotherapy by human Vγ2Vδ2 T cells against human prostate cancer.
Nada MH, Wang H, Hussein AJ, Tanaka Y, Morita CT
Oncoimmunology, 10(1):1989789, 25 Oct 2021
Cited by: 21 articles | PMID: 34712512 | PMCID: PMC8547840
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Glioblastoma cells potentiate the induction of the Th1-like profile in phosphoantigen-stimulated γδ T lymphocytes.
Rosso DA, Rosato M, Iturrizaga J, González N, Shiromizu CM, Keitelman IA, Coronel JV, Gómez FD, Amaral MM, Rabadan AT, Salamone GV, Jancic CC
J Neurooncol, 153(3):403-415, 14 Jun 2021
Cited by: 7 articles | PMID: 34125375
Add to export list
Human serum albumin and chromatin condensation rescue ex vivo expanded γδ T cells from the effects of cryopreservation.
Burnham RE, Tope D, Branella G, Williams E, Doering CB, Spencer HT
Cryobiology, 99:78-87, 21 Jan 2021
Cited by: 6 articles | PMID: 33485898 | PMCID: PMC7941345
Add to export list Free full text in Europe PMC
K-Ras prenylation as a potential anticancer target.
Baranyi M, Buday L, Hegedűs B
Cancer Metastasis Rev, 39(4):1127-1141, 01 Dec 2020
Cited by: 20 articles | PMID: 32524209 | PMCID: PMC7680335
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The BTLA and PD-1 signaling pathways independently regulate the proliferation and cytotoxicity of human peripheral blood γδ T cells.
Hwang HJ, Lee JJ, Kang SH, Suh JK, Choi ES, Jang S, Hwang SH, Koh KN, Im HJ, Kim N
Immun Inflamm Dis, 9(1):274-287, 17 Dec 2020
Cited by: 13 articles | PMID: 33332777 | PMCID: PMC7860523
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Characterization of Donor Variability for γδ T Cell ex vivo Expansion and Development of an Allogeneic γδ T Cell Immunotherapy.
Burnham RE, Zoine JT, Story JY, Garimalla SN, Gibson G, Rae A, Williams E, Bixby L, Archer D, Doering CB, Spencer HT
Front Med (Lausanne), 7:588453, 13 Nov 2020
Cited by: 21 articles | PMID: 33282892 | PMCID: PMC7691424
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Vγ9Vδ2 T Cells: Can We Re-Purpose a Potent Anti-Infection Mechanism for Cancer Therapy?
Künkele KP, Wesch D, Oberg HH, Aichinger M, Supper V, Baumann C
Cells, 9(4):E829, 30 Mar 2020
Cited by: 13 articles | PMID: 32235616 | PMCID: PMC7226769
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia.
Rozenbaum M, Meir A, Aharony Y, Itzhaki O, Schachter J, Bank I, Jacoby E, Besser MJ
Front Immunol, 11:1347, 02 Jul 2020
Cited by: 115 articles | PMID: 32714329 | PMCID: PMC7343910
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Emerging Challenges of Preclinical Models of Anti-tumor Immunotherapeutic Strategies Utilizing Vγ9Vδ2 T Cells.
Joalland N, Scotet E
Front Immunol, 11:992, 22 May 2020
Cited by: 4 articles | PMID: 32528477 | PMCID: PMC7256197
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Organ Biodistribution of Radiolabelled γδ T Cells Following Liposomal Alendronate Administration in Different Mouse Tumour Models.
Wang JT, Hodgins NO, Al-Jamal WT, Maher J, Sosabowski JK, Al-Jamal KT
Nanotheranostics, 4(2):71-82, 06 Feb 2020
Cited by: 7 articles | PMID: 32190534 | PMCID: PMC7064741
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Nanoformulated Zoledronic Acid Boosts the Vδ2 T Cell Immunotherapeutic Potential in Colorectal Cancer.
Di Mascolo D, Varesano S, Benelli R, Mollica H, Salis A, Zocchi MR, Decuzzi P, Poggi A
Cancers (Basel), 12(1):E104, 31 Dec 2019
Cited by: 15 articles | PMID: 31906080 | PMCID: PMC7017311
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Challenges in assessing solid tumor responses to immunotherapy.
Chai LF, Prince E, Pillarisetty VG, Katz SC
Cancer Gene Ther, 27(7-8):528-538, 11 Dec 2019
Cited by: 25 articles | PMID: 31822814
Add to export list Review
Cryoablation and Immunotherapy: An Enthralling Synergy to Confront the Tumors.
Yakkala C, Chiang CL, Kandalaft L, Denys A, Duran R
Front Immunol, 10:2283, 24 Sep 2019
Cited by: 38 articles | PMID: 31608067 | PMCID: PMC6769045
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Engineering γδT cells limits tonic signaling associated with chimeric antigen receptors.
Fisher J, Sharma R, Don DW, Barisa M, Hurtado MO, Abramowski P, Porter L, Day W, Borea R, Inglott S, Anderson J, Pe'er D
Sci Signal, 12(598):eaax1872, 10 Sep 2019
Cited by: 25 articles | PMID: 31506382 | PMCID: PMC7055420
Add to export list Free full text in Europe PMC
Ex Vivo Expanded Human Vγ9Vδ2 T-Cells Can Suppress Epithelial Ovarian Cancer Cell Growth.
Mao TL, Miao CH, Liao YJ, Chen YJ, Yeh CY, Liu CL
Int J Mol Sci, 20(5):E1139, 06 Mar 2019
Cited by: 9 articles | PMID: 30845699 | PMCID: PMC6429417
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Probing the Ligand-Binding Pocket of BTN3A1.
Poe MM, Agabiti SS, Liu C, Li V, Teske KA, Hsiao CC, Wiemer AJ
J Med Chem, 62(14):6814-6823, 03 Jul 2019
Cited by: 6 articles | PMID: 31268699 | PMCID: PMC7701984
Add to export list Free full text in Europe PMC
Impact on early outcomes and immune reconstitution of high-dose post-transplant cyclophosphamide vs anti-thymocyte globulin after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation.
Retière C, Willem C, Guillaume T, Vié H, Gautreau-Rolland L, Scotet E, Saulquin X, Gagne K, Béné MC, Imbert BM, Clemenceau B, Peterlin P, Garnier A, Chevallier P
Oncotarget, 9(14):11451-11464, 27 Jan 2018
Cited by: 34 articles | PMID: 29545911 | PMCID: PMC5837739
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local.
Pauza CD, Liou ML, Lahusen T, Xiao L, Lapidus RG, Cairo C, Li H
Front Immunol, 9:1305, 08 Jun 2018
Cited by: 56 articles | PMID: 29937769 | PMCID: PMC6003257
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer.
Hoeres T, Smetak M, Pretscher D, Wilhelm M
Front Immunol, 9:800, 19 Apr 2018
Cited by: 90 articles | PMID: 29725332 | PMCID: PMC5916964
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Valproic Acid Combined with Zoledronate Enhance γδ T Cell-Mediated Cytotoxicity against Osteosarcoma Cells via the Accumulation of Mevalonate Pathway Intermediates.
Wang S, Li H, Ye C, Lin P, Li B, Zhang W, Sun L, Wang Z, Xue D, Teng W, Zhou X, Lin N, Ye Z
Front Immunol, 9:377, 27 Feb 2018
Cited by: 12 articles | PMID: 29535738 | PMCID: PMC5835048
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 41 results

1 2

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

Antibody-Drug Conjugate Made of Zoledronic Acid and the Anti-CD30 Brentuximab-Vedotin Exert Anti-Lymphoma and Immunostimulating Effects.

Synthesis and evaluation of (E)-4-hydroxy-3-methyl-but-2-enyl diphosphate analogs as competitive partial agonists of butyrophilin 3A1.

Priming of Colorectal Tumor-Associated Fibroblasts with Zoledronic Acid Conjugated to the Anti-Epidermal Growth Factor Receptor Antibody Cetuximab Elicits Anti-Tumor Vδ2 T Lymphocytes.

Targeting of colorectal cancer organoids with zoledronic acid conjugated to the anti-EGFR antibody cetuximab.

Reducing farnesyl diphosphate synthase levels activates Vγ9Vδ2 T cells and improves tumor suppression in murine xenograft cancer models.

PD-1 checkpoint blockade enhances adoptive immunotherapy by human Vγ2Vδ2 T cells against human prostate cancer.

Glioblastoma cells potentiate the induction of the Th1-like profile in phosphoantigen-stimulated γδ T lymphocytes.

Human serum albumin and chromatin condensation rescue ex vivo expanded γδ T cells from the effects of cryopreservation.

K-Ras prenylation as a potential anticancer target.

The BTLA and PD-1 signaling pathways independently regulate the proliferation and cytotoxicity of human peripheral blood γδ T cells.

Characterization of Donor Variability for γδ T Cell ex vivo Expansion and Development of an Allogeneic γδ T Cell Immunotherapy.

Vγ9Vδ2 T Cells: Can We Re-Purpose a Potent Anti-Infection Mechanism for Cancer Therapy?

Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia.

Emerging Challenges of Preclinical Models of Anti-tumor Immunotherapeutic Strategies Utilizing Vγ9Vδ2 T Cells.

Organ Biodistribution of Radiolabelled γδ T Cells Following Liposomal Alendronate Administration in Different Mouse Tumour Models.

Nanoformulated Zoledronic Acid Boosts the Vδ2 T Cell Immunotherapeutic Potential in Colorectal Cancer.

Challenges in assessing solid tumor responses to immunotherapy.

Cryoablation and Immunotherapy: An Enthralling Synergy to Confront the Tumors.

Engineering γδT cells limits tonic signaling associated with chimeric antigen receptors.

Ex Vivo Expanded Human Vγ9Vδ2 T-Cells Can Suppress Epithelial Ovarian Cancer Cell Growth.

Probing the Ligand-Binding Pocket of BTN3A1.

Impact on early outcomes and immune reconstitution of high-dose post-transplant cyclophosphamide vs anti-thymocyte globulin after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation.

Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local.

Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer.

Valproic Acid Combined with Zoledronate Enhance γδ T Cell-Mediated Cytotoxicity against Osteosarcoma Cells via the Accumulation of Mevalonate Pathway Intermediates.

Partnerships & funding